AGILON HEALTH (AGL) — insider trading
Health Care · NYSE
AGILON HEALTH (AGL) has 31 reported SEC Form 4 insider transactions in our data (latest 2026-08-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-16 | Gertsch Timothy | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 17 | $96.90 | $1.6K | Form 4 |
| 2026-08-01 | Zamore Denise | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 37 | $91.61 | $3.4K | Form 4 |
| 2026-07-01 | Schwaneke Jeffrey A. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 2,311 | $111.74 | $258.2K | Form 4 |
| 2026-06-02 | Battaglia Silvana | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-02 | Mansukani Sharad | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-02 | MCKENZIE DIANA | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-02 | McLoughlin Karen | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-02 | WILLIAMS RONALD A | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-02 | Wulf John William | Director | Grant / award / vesting | 2,133 | — | $0 | Form 4 |
| 2026-06-01 | Zamore Denise | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 485 | $92.54 | $44.9K | Form 4 |
| 2026-05-24 | Gertsch Timothy | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 8 | $86.39 | $691 | Form 4 |
| 2026-05-07 | O'Rourke Timothy Patrick | Director, Officer (CEO & President) | Grant / award / vesting | 200,000 | — | $0 | Form 4 |
| 2026-05-07 | O'Rourke Timothy Patrick | Director, Officer (CEO & President) | Grant / award / vesting | 120,000 | — | $0 | Form 4 |
| 2026-04-15 | Shaker Benjamin | Officer (Chief Markets Officer) | Shares withheld for taxes / exercise cost | 571 | $26.88 | $15.3K | Form 4 |
| 2026-04-15 | Gertsch Timothy | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 122 | $26.88 | $3.3K | Form 4 |
| 2026-04-15 | Venkatachaliah Girish | Officer (Chief Technology Officer) | Shares withheld for taxes / exercise cost | 330 | $26.88 | $8.9K | Form 4 |
| 2026-04-15 | Zamore Denise | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 220 | $26.88 | $5.9K | Form 4 |
| 2026-04-14 | Shaker Benjamin | Officer (Chief Markets Officer) | Shares withheld for taxes / exercise cost | 104 | $22.68 | $2.4K | Form 4 |
| 2026-04-14 | Gertsch Timothy | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 25 | $22.68 | $567 | Form 4 |
| 2026-04-14 | Venkatachaliah Girish | Officer (Chief Technology Officer) | Shares withheld for taxes / exercise cost | 96 | $22.68 | $2.2K | Form 4 |
| 2026-04-14 | Zamore Denise | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 20 | $22.68 | $454 | Form 4 |
| 2026-04-01 | Zamore Denise | Officer (Chief Legal Officer) | Grant / award / vesting | 50,000 | — | $0 | Form 4 |
| 2026-04-01 | Zamore Denise | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 1,024 | $9.75 | $10.0K | Form 4 |
| 2026-04-01 | Venkatachaliah Girish | Officer (Chief Technology Officer) | Grant / award / vesting | 28,000 | — | $0 | Form 4 |
| 2026-04-01 | Venkatachaliah Girish | Officer (Chief Technology Officer) | Shares withheld for taxes / exercise cost | 480 | $9.75 | $4.7K | Form 4 |
| 2026-04-01 | Gertsch Timothy | Officer (Chief Accounting Officer) | Grant / award / vesting | 10,000 | — | $0 | Form 4 |
| 2026-04-01 | Gertsch Timothy | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 266 | $9.75 | $2.6K | Form 4 |
| 2026-04-01 | Shaker Benjamin | Officer (Chief Markets Officer) | Grant / award / vesting | 70,000 | — | $0 | Form 4 |
| 2026-04-01 | Shaker Benjamin | Officer (Chief Markets Officer) | Shares withheld for taxes / exercise cost | 1,664 | $9.75 | $16.2K | Form 4 |
| 2026-04-01 | Schwaneke Jeffrey A. | Officer (Chief Financial Officer) | Grant / award / vesting | 75,000 | — | $0 | Form 4 |
| 2026-04-01 | Schwaneke Jeffrey A. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,662 | $9.75 | $16.2K | Form 4 |
Ask the chat about AGL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AGILON HEALTH (AGL).
Last updated 2026-08-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.